Prions in the Gut: Dietary Proteins or Infectious Pathogens?

How do orally ingested infectious prions find their way to the brain? An article by Ricki Lewis in this issue of The Scientist (See "Portals for Prions?") describes recent hypotheses about trafficking of prions from gastrointestinal tract via lymphoid cells to the central nervous system. The most attractive point of entry for the ingested prions seems to be directly in the gut, where contaminated food is first deposited. Gastroenterologists have long known about the specialized subpopulation of

Written byIwona Stroynowski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Recent studies suggest that m cells do not break down orally administered antigens; this function, and the subsequent presentation of processed antigens to T cells, is carried out by bone marrow-derived APC, probably DC.2 Precursors of m cells, enterocytes (EC), are also implicated in transcytosis of some intact particles and, indirectly, in presentation of processed antigens to T cells.

What happens to antigens that pass the intestinal transepithelial barrier? Intact macromolecules, including dietary proteins, can be found in blood, suggesting existence of a direct pathway for circulating undigested, gut-derived proteins into remote tissues. More interesting is the fate of antigens entering mucosal immune tissue. It is here that the immune system starts to sort out the antigens into harmless dietary proteins that need to be tolerated, and potentially dangerous pathogens that must be met with an effective immune response to prevent the spread of infection to other organs. The key ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies